Imbruvica and Oxycodone hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imbruvica (ibrutinib) and Oxycodone hydrochloride (oxycodone hydrochloride). Common drug interactions include oedema among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Imbruvica and Oxycodone hydrochloride. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Imbruvica?

Imbruvica has active ingredients of ibrutinib. It is often used in chronic lymphocytic leukemia (cll). eHealthMe is studying from 70,020 Imbruvica users. Check the latest studies of Imbruvica.

What is Oxycodone hydrochloride?

Oxycodone hydrochloride has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 36,817 Oxycodone hydrochloride users. Check the latest studies of Oxycodone hydrochloride.



On Jul, 06, 2026

30 people who take Imbruvica and Oxycodone hydrochloride together, and have interactions are studied.

Imbruvica and Oxycodone hydrochloride drug interactions.

What are the common drug interactions of Imbruvica and Oxycodone Hydrochloride, by gender? *:

female:

  1. Oedema (fluid collection in tissue)
  2. Osteonecrosis (death of bone)
  3. Skin hypopigmentation (loss of skin colour)
  4. Skin wound
  5. Trismus (reduced opening of the jaws)
  6. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  7. Weight increased
  8. Wound
  9. Blood disorder
  10. Blood lactate dehydrogenase increased

male:

  1. Asthenia (weakness)
  2. Fatigue (feeling of tiredness)
  3. Cough
  4. Drug ineffective
  5. Gingival pain (gum pain)
  6. Haemoglobin decreased
  7. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  8. Nausea (feeling of having an urge to vomit)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Platelet count decreased

What are the common drug interactions of Imbruvica and Oxycodone Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Abdominal distension
  4. Anaemia of chronic disease
  5. Arthralgia (joint pain)
  6. Cataract (clouding of the lens inside the eye)
  7. Cough
  8. Depressed mood
  9. Drug intolerance (drug sensitivity)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

40-49:

n/a

50-59:

n/a

60+:

  1. Pneumonia
  2. Asthenia (weakness)
  3. Fatigue (feeling of tiredness)
  4. Gingival pain (gum pain)
  5. Haemoglobin decreased
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  7. Nausea (feeling of having an urge to vomit)
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  9. Platelet count decreased
  10. Platelet count increased

What are the existing conditions these people have? *

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 20.00%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 13.33%
  3. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 3 people, 10.00%
  4. Stress And Anxiety: 2 people, 6.67%
  5. Mantle Cell Lymphoma Stage Iv (cancer of lymphocytes, a type of white blood cell, spreads to other part of body): 2 people, 6.67%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.67%
  7. Depression: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Imbruvica and Oxycodone hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imbruvica and Oxycodone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imbruvica:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxycodone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imbruvica and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ibrutinib and oxycodone hydrochloride (the active ingredients of Imbruvica and Oxycodone hydrochloride, respectively), and Imbruvica and Oxycodone hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: